Valuation China Shineway Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 11:59:05 29/10/2026 +04			5-day change	1st Jan Change
7.275 ^HKD	+0.07%		+0.76%	-15.41%

09-29	China Shineway Pharmaceutical Group Limited Announces Board and Committee Changes, Effective 1 October 2026	CI
09-18	China Shineway Pharmaceutical Group Limited Declares Special Interim Dividend in Respect of the Fiscal Year Ending 31 December 2026, Payable on 15 October 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,240	5,072	4,985	6,850	5,838	4,667	-	-
Change	-	19.61%	-1.71%	37.41%	-14.78%	-20.06%	-	-
Enterprise Value (EV)	49.32	25.13	4,985	6,850	5,838	4,667	4,667	4,667
Change	-	-49.04%	19,734.74%	37.41%	-14.78%	-20.06%	0%	0%
P/E	7.59x	6.99x	5.16x	8.17x	6.13x	6.18x	5.75x	5.41x
PBR	0.72x	0.79x	0.71x	-	0.72x	0.59x	-	-
PEG	-	0.2x	0.2x	-0.6x	0.5x	-0.3x	0.78x	0.84x
Capitalization / Revenue	1.32x	1.28x	1.1x	1.81x	1.86x	1.99x	1.99x	1.92x
EV / Revenue	0x	0x	0x	0x	0x	1.99x	1.99x	1.92x
EV / EBITDA	0x	0x	0x	0x	0x	5.74x	5.4x	5.12x
EV / EBIT	0x	0x	0x	0x	0x	5.74x	5.4x	5.12x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	0.39	0.32	0.42	0.54	-	-	-	-
Rate of return	6.95%	4.77%	6.36%	5.95%	-	-	-	-
EPS ²	0.74	0.96	1.28	1.11	1.26	1	1.074	1.143
Distribution rate	52.7%	33.3%	32.8%	48.6%	-	-	-	-
Net sales ¹	3,224	3,951	4,517	3,778	3,135	2,344	2,347	2,427
EBITDA ¹	826	1,022	1,316	1,306	1,047	813	865	911
EBIT ¹	643.6	835.8	1,139	1,025	896	813	865	911
Net income ¹	556.7	722.8	969.5	840.1	949.9	755	811	864
Net Debt	-4,191	-5,046	-	-	-	-	-	-
Reference price ²	5.613	6.714	6.599	9.068	7.728	6.178	6.178	6.178
Nbr of stocks (in thousands)	755,400	755,400	755,400	755,400	755,400	755,400	-	-
Announcement Date	29/03/22	30/03/23	28/03/24	28/03/25	27/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED	6.18x	-	-	-	700M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	27.23x	7.11x	18.84x	2.11%	403.79B
Weighted average by Cap.	35.28x	8.40x	20.64x	1.79%